PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33548287-10	2021	However, the combined administration of OLT1177 with BBG potentiated its inhibitory effect on the NLRP3, which was reflected by the additional suppressive effect on caspase-1, IL-1beta, IL-18 levels.	coomassie Brilliant Blue	53-56	interleukin 1 alpha	Rattus norvegicus	176-184	
33548287-9	2021	Individual BBG or OLT1177 administration decreased NLRP3 inflammasome recruitment and subsequent activation of caspase-1, IL-1beta, and IL-18.	coomassie Brilliant Blue	11-14	interleukin 1 alpha	Rattus norvegicus	122-130	
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	25-41	interleukin 1 alpha	Rattus norvegicus	175-183	
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	43-46	interleukin 1 alpha	Rattus norvegicus	175-183	
32516946-7	2020	Increased IL-2, IL-6, TNFalpha, IL-1beta, IL-18 and overexpression of NLRP3 inflammasome were induced by angiotensin II and suppressed by BBG.	coomassie Brilliant Blue	138-141	interleukin 1 alpha	Rattus norvegicus	32-40